Summary
• Mechanisms responsible for the pathological deposition of redox-active iron in the aging and degenerating human brain remain incompletely understood.
• Heme oxygenase-1 (HO-1) is a 32-kDa stress protein that degrades heme to biliverdin, free iron, and carbon monoxide.
• Brain HO-1 expression increases with advancing age, and the enzyme is further induced in CNS tissues affected by Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative and neuroinflammatory conditions.
• Upregulation of HO-1 in astrocytes exacerbates intracellular oxidative stress and promotes sequestration of non-transferrin-derived iron by the mitochondrial compartment.
• The glial mitochondrial iron catalyzes the bio-activation of protoxins (e.g., catechols, MPTP) to potent neurotoxins (o-semiquinones, MPP+) and may further facilitate neural injury by attenuating glutathione biosynthesis and other ATP-dependent processes.
• Suppression of glial HO-1 induction or activity may constitute a rational therapeutic approach to curtail pathological iron deposition and mitochondrial insufficiency in disorders of the aging human CNS.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anthony, S. G., Schipper, H. M., Tavares, R., Hovanesian, V., Cortez, S. C., Stopa, E. G., et al. (2003). Stress protein expression in the Alzheimer-diseased choroid plexus. Journal of Alzheimer’s Disease, 5(3), 171–177.
Baranano, D. E., & Snyder, S. H. (2001). Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proceedings of the National Academy of Sciences, USA, 98(20), 10996–11002.
Beal, M. (1995). Mitochondrial dysfunction and oxidative damage in neurodegenerative diseases. Austin, TX: R.G. Landes Co.
Beal, M. F. (1996). Mitochondria, free radicals, and neurodegeneration. Current Opinion in Neurobiology, 6(5), 661–666.
Bonilla, E., Tanji, K., Hirano, M., Vu, T. H., DiMauro, S., & Schon, E. A. (1999). Mitochondrial involvement in Alzheimer's disease. Biochimica et Biophysica Acta, 1410(2), 171–182.
Bowen, B. C., Block, R. E., Sanchez-Ramos, J., Pattany, P. M., Lampman, D. A., Murdoch, J. B., et al. (1995). Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR American Journal of Neuroradiology, 16(1), 61–68.
Brawer, J. R., Reichard, G., Small, L., & Schipper, H. M. (1994). The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Research, 633(1–2), 9–20.
Brawer, J. R., & Sonnenschein, C. (1975). Cytopathological effects of estradiol on the arcuate nucleus of the female rat. A possible mechanism for pituitary tumorigenesis. American Journal of Anatomy, 144(1), 57–88.
Brawer, J. R., Stein, R., Small, L., Cisse, S., & Schipper, H. M. (1994). Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus. Anatomical Record, 240(3), 407–415.
Broekemeier, K. M., & Pfeiffer, D. R. (1995). Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases. Biochemistry, 34(50), 16440–16449.
Businaro, R., Fabrizi, C., Caronti, B., Calderaro, C., Fumagalli, L., & Lauro, G. M. (2002). Myelin basic protein induces heme oxygenase-1 in human astroglial cells. Glia, 37(1), 83–88.
Butterfield, D. A. (2002). Amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Research, 36(12), 1307–1313.
Butterfield, D. A., Castegna, A., Lauderback, C. M., & Drake, J. (2002). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiology of Aging, 23(5), 655–664.
Calne, D. B. (1994). Neurodegenerative diseases. Philadelphia: W.B. Saunders Co.
Castellani, R., Smith, M. A., Richey, P. L., & Perry, G. (1996). Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Research, 737(1–2), 195–200.
Cissé, S., & Schipper, H. M. (1995). Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropathology and Applied Neurobiology, 21(5), 423–431.
Connor, J. R. (1997). Metals and oxidative damage in neurological disorders. New York: Plenum Press.
Converso, D. P., Taille, C., Carreras, M. C., Jaitovich, A., Poderoso, J. J., & Boczkowski, J. (2006). HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. The Federation of American Societies for Experimental Biology Journal, 20(8), 1236–1238.
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., et al. (1994). Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics, 23(2), 471–476.
Dennery, P. A. (2000). Regulation and role of heme oxygenase in oxidative injury. Current Topics in Cellular Regulation, 36, 181–199.
DiMonte, D., Schipper, H., Hetts, S., & Langston, J. (1995). Iron-mediated bioactivation of 1-methl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia, 15, 203–206.
Dore, S., Takahashi, M., Ferris, C. D., Zakhary, R., Hester, L. D., Guastella, D., et al. (1999). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proceedings of the National Academy of Sciences, USA, 96(5), 2445–2450.
Frankel, D., Mehindate, K., & Schipper, H. M. (2000). Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. Journal of Cellular Physiology, 185(1), 80–86.
Frankel, D., & Schipper, H. M. (1999). Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury. Experimental Neurology, 160(2), 376–385.
Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., et al. (1994). Altered cerebral energy metabolism in Alzheimer's disease: A PET study. Journal of Nuclear Medicine, 35(1), 1–6.
Gibson, G. E., Sheu, K. F., & Blass, J. P. (1998). Abnormalities of mitochondrial enzymes in Alzheimer disease. Journal of Neural Transmission, 105(8–9), 855–870.
Ham, D., & Schipper, H. M. (2000). Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cellular and Molecular Biology (Noisy-le-grand), 46(3), 587–596.
Hirose, W., Ikematsu, K., & Tsuda, R. (2003). Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Legal Medicine (Tokyo), 5(Suppl.), S360–S366.
Jefferies, W. A., Food, M. R., Gabathuler, R., Rothenberger, S., Yamada, T., Yasuhara, O., et al. (1996). Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Research, 712(1), 122–126.
Jenner, P. (2003). Oxidative stress in Parkinson's disease. Annals of Neurology, 53(Suppl. 3), S26–S36; discussion S36–S28.
Jofre-Monseny, L., Loboda, A., Wagner, A. E., Huebbe, P., Boesch-Saadatmandi, C., Jozkowicz, A., et al. (2007). Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochemical and Biophysical Research Communications, 357(1), 319–324.
Kim, H. P., Wang, X., Galbiati, F., Ryter, S. W., & Choi, A. M. (2004). Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. The Federation of American Societies for Experimental Biology Journal, 18(10), 1080–1089.
Kimpara, T., Takeda, A., Watanabe, K., Itoyama, Y., Ikawa, S., Watanabe, M., et al. (1997). Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Human Genetics, 100(1), 145–147.
Lee, E. Y., & Lee, K. L. (2001). Accumulation of peroxidase-positive granules with ageing in SAMP and 10 SAMR1 mouse brains. Korean Journal of Anatomy, 34, 645–651.
LeVine, S. M. (1997). Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Research, 760(1–2), 298–303.
Llesuy, S. F., & Tomaro, M. L. (1994). Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochimica et Biophysica Acta, 1223(1), 9–14.
Maes, O. C., Kravitz, S., Mawal, Y., Su, H., Liberman, A., Mehindate, K., et al. (2006). Characterization of alpha(1)-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiology of Disease, 24, 89–100.
Mattson, M. P. (2002). Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease. International Review of Neurobiology, 53, 387–409.
Mawal, Y., Berlin, D., Kravitz, S., & Schipper, H. (2002). Heme oxygenase-1 and Alzheimer disease. In N. G. Abraham, J. Alam, & K. A. Nath (Ed.), Heme oxygenase in biology and medicine (pp. 145–155). New York: Kluwer Academic/Plenum Publishers.
McGeer, P. L., & McGeer, E. G. (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Brain Research Reviews, 21(2), 195–218.
McLaren, J., Brawer, J. R., & Schipper, H. M. (1992). Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. Journal of Histochemistry and Cytochemistry, 40(12), 1887–1897.
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., et al. (2001). Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. Journal of Neurochemistry, 77(5), 1386–1395.
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997). Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Annals of Neurology, 42(1), 85–94.
Miyajima, H., Kono, S., Takahashi, Y., & Sugimoto, M. (2002). Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cells Molecules and Diseases, 29(3), 433–438.
Mydlarski, M. B., Brawer, J. R., & Schipper, H. M. (1998). The peroxidase-positive subcortical glial system. In H. M. Schipper (Ed.), Astrocytes in brain aging and neurodegeneration (pp. 191–206). Austin: R.G. Landes Co.
Nakagami, T., Toyomura, K., Kinoshita, T., & Morisawa, S. (1993). A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochimica et Biophysica Acta, 1158(2), 189–193.
Petronilli, V., Cola, C., Massari, S., Colonna, R., & Bernardi, P. (1993). Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. Journal of Biological Chemistry, 268(29), 21939–21945.
Piantadosi, C. A., Carraway, M. S., & Suliman, H. B. (2006). Carbon monoxide, oxidative stress, and mitochondrial permeability pore transition. Free Radical Biology and Medicine, 40(8), 1332–1339.
Ponka, P. (2004). Hereditary causes of disturbed iron homeostasis in the central nervous system. Annals of the New York Academy of Sciences, 1012, 267–281.
Reichmann, H., & Riederer, P. (1994). Mitochondrial disturbances in neurodegeneration. Philadelphia: Saunders.
Ryter, S. W., & Tyrrell, R. M. (2000). The heme synthesis and degradation pathways: Role in oxidant sensitivity. Heme oxygenase has both pro- and anti-oxidant properties. Free Radical Biology and Medicine, 28(2), 289–309.
Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43(8), 1467–1472.
Sayre, L. M., Smith, M. A., & Perry, G. (2001). Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Current Medical Chemistry, 8(7), 721–738.
Schipper, H., Scarborough, D., Lechan, R., & Reichlin, S. (1990). Gomori-positive astrocytes in primary culture: Effects of in vitro age and cysteamine exposure. Developmental Brain Research, 54, 71.
Schipper, H. M. (1996). Astrocytes, brain aging, and neurodegeneration. Neurobiology of Aging, 17(3), 467–480.
Schipper, H. M. (1998). Glial iron sequestration and neurodegeneration. In H. M. Schipper (Ed.), Astrocytes in brain aging and neurodegeneration (pp. 235–251). Austin: R.G. Landes Co.
Schipper, H. M. (1999). Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotoxicity Research, 1(1), 57–70.
Schipper, H. M. (2000). Heme oxygenase-1: Role in brain aging and neurodegeneration. Experimental Gerontology, 35(6–7), 821–830.
Schipper, H. M. (2001). Mitochondrial iron deposition in aging astroglia: Mechanisms and disease implications. In M. Ebadi, J. Marwah, & R. K. Chopra (Eds.), Mitochondrial ubiquinone (Coenzyme Q): Biochemical, functional, medical, and therapeutic aspects in human health and disease (pp. 267–280). Scottsdale, AZ: Prominent Press.
Schipper, H. M. (2004a). Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Research Reviews, 3, 265–301.
Schipper, H. M. (2004b). Heme oxygenase-1: Transducer of pathological brain iron sequestration under oxidative stress. In S. LeVine, J. R. Connor, & H. M. Schipper (Eds.), Redox-active metals in neurological disorders (Vol. 1012, pp. 84–93). New York: Annals of the New York Academy of Sciences.
Schipper, H. M., Bennett, D. A., Liberman, A., Bienias, J. L., Schneider, J. A., Kelly, J., et al. (2006). Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiology of Aging, 27(2), 252–261.
Schipper, H. M., Bernier, L., Mehindate, K., & Frankel, D. (1999). Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. Journal of Neurochemistry, 72(5), 1802–1811.
Schipper, H. M., Chertkow, H., Mehindate, K., Frankel, D., Melmed, C., & Bergman, H. (2000). Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology, 54(6), 1297–1304.
Schipper, H. M., & Cissé, S. (1995). Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia, 14(1), 55–64.
Schipper, H. M., Cissé, S., & Stopa, E. G. (1995). Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Annals of Neurology, 37(6), 758–768.
Schipper, H. M., Kotake, Y., & Janzen, E. G. (1991). Catechol oxidation by peroxidase-positive astrocytes in primary culture: An electron spin resonance study. Journal of Neuroscience, 11(7), 2170–2176.
Schipper, H. M., Liberman, A., & Stopa, E. G. (1998). Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Experimental Neurology, 150(1), 60–68.
Schipper, H. M., Mydlarski, M. B., & Wang, X. (1993). Cysteamine gliopathy in situ: A cellular stress model for the biogenesis of astrocytic inclusions. Journal of Neuropathology and Experimental Neurology, 52(4), 399–410.
Schipper, H. M., Small, L., Wang, X., & Brawer, J. R. (2002). Role of porphyrin sequestration in the biogenesis of iron-laden astrocytic inclusions in primary culture. Developmental Neuroscience, 24(2–3), 169–176.
Schipper, H. M., Vininsky, R., Brull, R., Small, L., & Brawer, J. R. (1998). Astrocyte mitochondria: A substrate for iron deposition in the aging rat substantia nigra. Experimental Neurology, 152(2), 188–196.
Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease. Neuron, 6(4), 487–498.
Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., et al. (1994). Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. American Journal of Pathology, 145(1), 42–47.
Song, L., Song, W., & Schipper, H. M. (2007). Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. Journal of Neuroscience Research, 85(10), 2186–2195.
Song, W., Su, H., Song, S., Paudel, H. K., & Schipper, H. M. (2006). Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. Journal of Cellular Physiology, 206(3), 655–663.
Soong, N. W., Hinton, D. R., Cortopassi, G., & Arnheim, N. (1992). Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genetics, 2(4), 318–323.
St-Jacques, R., Chapman, A., Lacaille, J. C., Mohr, G., & Schipper, H. M. (1999). Acceleration of ageing-related gliopathic changes and hippocampal dysfunction following intracerebroventricular infusion of cysteamine in adult rats. Neuroscience, 90(3), 1103–1113.
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987). Bilirubin is an antioxidant of possible physiological importance. Science, 235(4792), 1043–1046.
Storm, T., Rath, S., Mohamed, S. A., Bruse, P., Kowald, A., Oehmichen, M., et al. (2002). Mitotic brain cells are just as prone to mitochondrial deletions as neurons: A large-scale single-cell PCR study of the human caudate nucleus. Experimental Gerontology, 37(12), 1389–1400.
Tanno, Y., Okuizumi, K., & Tsuji, S. (1998). mtDNA polymorphisms in Japanese sporadic Alzheimer's disease. Neurobiology of Aging, 19(Suppl. 1), S47–51.
Vaya, J., Song, W., Khatib, S., Geng, G., & Schipper, H. M. (2007). Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radical Biology and Medicine, 42(6), 864–871.
Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993). Carbon monoxide: a putative neural messenger. Science, 259(5093), 381–384.
Wang, X., Manganaro, F., & Schipper, H. M. (1995). A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system. Journal of Neurochemistry, 64(4), 1868–1877.
Yu, H.-L., Chertkow, H. M., Bergman, H., & Schipper, H. M. (2003). Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics, 3, 2240–2248.
Zhang, J., & Piantadosi, C. A. (1992). Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. Journal of Clinical Investigation, 90(4), 1193–1199.
Acknowledgments
The author thanks Adrienne Liberman for assistance with the preparation of this manuscript. Contributions by the Schipper laboratory were enabled by grants from the Canadian Institutes of Health Research, the Fonds de la Recherche en Santé du Québec, the Alzheimer’s Association (US), and the Parkinson Foundation of Canada.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schipper, H.M. (2009). Brain Iron Deposition in Aging and Disease: Role of HO-1. In: Yehuda, S., Mostofsky, D. (eds) Iron Deficiency and Overload. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-462-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-462-9_7
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-934115-22-0
Online ISBN: 978-1-59745-462-9
eBook Packages: MedicineMedicine (R0)